Circulatory effects of sympathomimetic amines

American Heart Journal


No abstract listed.


Oct 1, 1952·Circulation·S M SANCETTAH JANOUSKOVEC
Sep 10, 1952·Acta Physiologica Scandinavica·A LUNDBERG
Jul 25, 1953·Journal of the American Medical Association·A J MILLERL N KATZ
Dec 1, 1953·The Journal of Clinical Investigation·E D FREISR L JOHNSON
May 1, 1954·American Heart Journal·W R LIVESAYD W CHAPMAN
Sep 1, 1954·The American Journal of Physiology·S M HORVATH, D W KNAPP
Feb 26, 1955·Journal of the American Medical Association·C K DONEGAN, C V TOWNSEND
Sep 1, 1955·A.M.A. Archives of Internal Medicine·W H HALL, D GOLD
Oct 1, 1955·American Heart Journal·J T MCGINN, J SCHLUGER
Feb 1, 1956·The Laryngoscope·M GOODMAN
Jun 1, 1956·American Heart Journal·G E BURCH, M MURTADHA
Aug 1, 1956·The Journal of Clinical Investigation·A C CORCORANI H PAGE
Sep 1, 1956·Circulation Research·L D MACLEAN, M H WEIL
Jul 1, 1956·Proceedings of the Society for Experimental Biology and Medicine·L B HINSHAWM H WEIL
Nov 1, 1956·The Journal of Clinical Investigation·L D MACLEANM H WEIL
Jan 1, 1957·Canadian Journal of Biochemistry and Physiology·C W GOWDEYJ A STEVENSON
Mar 1, 1957·Circulation·G ENTWISLE, E HALE
Mar 1, 1957·Modern Concepts of Cardiovascular Disease·J J SAMPSON
Mar 7, 1957·Acta Physiologica Scandinavica·H DUNER, U S VON EULER
Jan 1, 1957·American Journal of Clinical Pathology·G A BOUGHTON, S C SOMMERS
Apr 1, 1957·The American Journal of the Medical Sciences·L C MILLS, J H MOYER
Apr 20, 1957·Journal of the American Medical Association·G ZUCKER
Jan 1, 1957·The Journal of Pharmacology and Experimental Therapeutics·D M AVIADO, A L WNUCK
May 1, 1957·Circulation Research·S M FRIEDMANM NAKASHIMA
Jun 1, 1957·The Journal of Clinical Investigation·B COMBESS E BRADLEY
Aug 30, 1957·Science·J AXELROD
Aug 1, 1957·Biochimica Et Biophysica Acta·M D ARMSTRONGK N SHAW
Nov 1, 1957·The American Journal of Physiology·J C ROSE, E D FREIS
Jan 18, 1958·British Medical Journal·J H BURN, M J RAND

❮ Previous
Next ❯


Jan 1, 1993·European Journal of Applied Physiology and Occupational Physiology·G M BuddA T Solaga
Feb 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·G T BolgerP Skolnick
Dec 1, 1989·Journal of the American College of Cardiology·G L Bakris, E D Frohlich
Nov 14, 1963·The New England Journal of Medicine·L I GOLDBERGA M ZIMMERMAN
Oct 1, 1976·British Journal of Clinical Pharmacology·D A RichardsB N Prichard
Sep 1, 1988·The Journal of Clinical Investigation·E MignotW C Dement
Sep 7, 2000·Journal of Clinical Pharmacology·E Basta, G L Bakris
Jun 1, 1982·American Heart Journal·M Artman, T P Graham
Mar 1, 1983·American Heart Journal·M ArtmanT P Graham
Nov 1, 1968·American Heart Journal·N Krasnow
Mar 1, 1968·American Heart Journal·L I Goldberg
Dec 1, 1963·Arthritis and Rheumatism·E A STROM, J D COFFMAN
Apr 1, 1986·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·G K MooreC W Cummings
Oct 1, 1973·Circulation Research·W T Hardaker, A S Wechsler
Jan 1, 1987·Medical Toxicology·K R OlsonM T Kelley
Aug 15, 2017·Journal of Veterinary Pharmacology and Therapeutics·D N Q CunhaR L Hamlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved